4//SEC Filing
Raykov Rosty 4
Accession 0001468316-25-000009
CIK 0001211583other
Filed
Oct 7, 8:00 PM ET
Accepted
Oct 8, 5:08 PM ET
Size
7.2 KB
Accession
0001468316-25-000009
Insider Transaction Report
Form 4
Raykov Rosty
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common shares
2025-10-08$2.45/sh+4,609$11,292→ 87,110 total - Exercise/Conversion
Stock Options
2025-10-08$2.45/sh−4,609$11,292→ 1,634,184 totalExercise: $2.45From: 2016-07-05Exp: 2026-07-05→ options (4,609 underlying)
Footnotes (1)
- [F1]Shares acquired through the exercise of an option contract with strike price of $2.45 and an expiration date of July 5, 2026.
Documents
Issuer
FENNEC PHARMACEUTICALS INC.
CIK 0001211583
Entity typeother
Related Parties
1- filerCIK 0001468316
Filing Metadata
- Form type
- 4
- Filed
- Oct 7, 8:00 PM ET
- Accepted
- Oct 8, 5:08 PM ET
- Size
- 7.2 KB